Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  Published: 17 March 2014

  2422

  PDF: 1306
• 

  Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature

  M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR

  143-166

  31-10-2013

  Published: 31 October 2013

  6649

  PDF: 2419
• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  Published: 9 September 2016

  2863

  PDF: 2130
• 

  The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation

  S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini

  45-56

  16-09-2015

  Published: 16 September 2015

  1897

  PDF: 1032
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  Published: 6 November 2014

  2122

  PDF: 1506
• 

  Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

  J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

  57-61

  16-09-2015

  Published: 16 September 2015

  1989

  PDF: 985

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  Published:

  1191

  PDF: 634
• 

  Intra-articular therapy with tumor necrosis factor-α antagonists: an update

  S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

  257-263

  14-03-2014

  Published: 14 March 2014

  2401

  PDF: 1175

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  Published:

  1187

  PDF: 1007
• 

  Italian Society of Rheumatology recommendations for the management of gout

  M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

  4-21

  28-03-2013

  Published: 28 March 2013

  5491

  PDF: 1475

• Safety of lornoxicam in G-6-PDH deficiency

  G. Perpignano, E. Cacace, C. Matulli, V. Ruggiero

  45-47

  Published:

  726

  PDF: 524
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  Published: 19 December 2023

  1550

  PDF: 348

• Two-years therapy with bosentan of pulmonary arterial hypertension related to connective tissue diseases

  H. Marotta, R. Montisci, F. Tiso, S. Pontarollo, M. Rizzo, F. Tona, S. Iliceto, F. Cozzi

  299-303

  Published:

  869

  PDF: 689
• 

  Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases

  R. Deniz, N. Güner, Ş.A. Ekmen, İ.N. Mutlu, D.S. Özgür, B. Karaalioğlu, G. Akkuzu, F. Yıldırım, K. Kalkan, G. Güzelant-Özköse, B. İnce, M. Erdoğan, Y. Özlük, I. Kılıçaslan, C. Bes

  18-09-2023

  Published: 18 September 2023

  1066

  PDF: 387

• Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

  M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

  140-144

  Published:

  771

  PDF: 1121

• Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

  V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

  244-261

  Published:

  1236

  PDF: 1070

• Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip

  A. Migliore, S. Tormenta, L.S. Martin Martin, C. Valente, U. Massafra, A. Latini, A. Alimonti

  104-109

  Published:

  1164

  PDF: 984

• Safety of anti-TNFa biological drugs

  F. Trotta, G. Valentini

  34-39

  Published:

  1074

  PDF: 1070
• 

  Are biological drugs safe in pregnancy?

  A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

  304-317

  31-03-2015

  Published: 31 March 2015

  3443

  PDF: 2309
• 

  Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

  M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

  29-12-2022

  Published: 29 December 2022

  1596

  PDF: 708
• 

  Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

  M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

  285-303

  31-03-2015

  Published: 31 March 2015

  2339

  PDF: 2190

• Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

  C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

  224-235

  Published:

  1049

  PDF: 2296

• Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

  C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

  32-37

  Published:

  1550

  PDF: 707

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  Published:

  1126

  PDF: 757

• The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

  L. Riente

  74-79

  Published:

  708

  PDF: 869

• Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

  S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

  46-50

  Published:

  1059

  PDF: 1277

• BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

  D.D. Gladman

  85-87

  Published:

  601

  PDF: 538

• Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

  G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

  145-150

  Published:

  956

  PDF: 683

• The treatment of recurrent uveitis with TNFα inhibitors

  P.C.F. Falappone, F. Iannone, C. Scioscia, V. Grattagliano, M. Covelli, G. Lapadula

  185-189

  Published:

  1687

  PDF: 2294

• Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis

  K.V. Ilic, M. Sefik-Bukilica, S. Jankovic, N. Vujasinovic-Stupar

  27-33

  Published:

  1428

  PDF: 1073

• Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

  G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

  261-267

  Published:

  1136

  PDF: 661

• Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

  P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

  290-295

  Published:

  1987

  PDF: 1035
• 

  The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis

  I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia

  21-03-2023

  Published: 21 March 2023

  743

  PDF: 481

• Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  D. Camellino, C. Dejaco, F. Martini, R. Cosso, G. Bianchi

  28-10-2024

  Published: 28 October 2024

  235

  PDF: 88

• Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

  C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

  209-214

  Published:

  861

  PDF: 995

• Treatment of Wegener’s granulomatosis

  V. Riccieri, G. Valesini

  69-76

  Published:

  1285

  PDF: 4945

• Current therapeutic strategies for HCV-associated cryoglobulinemia

  F. Iannuzzella, G. Garini

  163-173

  Published:

  987

  PDF: 1957

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  Published:

  996

  PDF: 1548

• Psoriasis in women with psoriatic arthritis: hormonal effects, fertility, and considerations for management at different stages of life

  F. Cassalia, A. Belloni Fortina

  11-09-2024

  Published: 11 September 2024

  1169

  PDF: 291

• Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

  N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

  202-208

  Published:

  1370

  PDF: 1222

• Neprhrotic syndrome in a patient with rheumatoid arthritis treated with adalimumab: a case report

  M.G. Portuesi, P. Perosa

  61-63

  Published:

  1118

  PDF: 843
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  Published: 23 July 2020

  684

  PDF: 514

• Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

  P. Ostuni, M.E.C. Battista, A. Furlan

  119-124

  Published:

  922

  PDF: 1945

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  Published:

  1586

  PDF: 960

• Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

  E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

  24-06-2024

  Published: 24 June 2024

  1222

  PDF: 438
• 

  The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis

  S. Parisi, A. Bortoluzzi, G.D. Sebastiani, F. Conti, R. Caporali, N. Ughi, I. Prevete, A. Ariani, M. Manara, G. Carrara, C.A. Scirè

  22-49

  23-09-2019

  Published: 23 September 2019

  7312

  PDF: 2137

• A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib

  F.M. Mariani, A. Alunno, F. Carubbi, C. Ferri

  24-06-2024

  Published: 24 June 2024

  1071

  PDF: 377

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  Published:

  964

  PDF: 897

• Analgesic dose range finding of lornoxicam compared to diclofenac. Crossover double blind study in rheumatoid arthritis

  G.P. Pasero, O. Di Munno

  238-242

  Published:

  3664

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  Published:

  1200

  PDF: 1867